Recent Finacing
Recent Raise
Akarna Therapeutics is a biopharmaceutical company based in Cambridge and San Diego developing small-molecule FXR agonists for inflammatory/fibrotic diseases, with a lead NASH candidate in IND‑enabling preclinical studies.
Focus Areas
Recent Investors
Total Raised
Funding round
Investors